These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 26442580)

  • 21. Clonal alteration of breast cancer receptors between primary ductal carcinoma in situ (DCIS) and corresponding local events.
    Karlsson E; Sandelin K; Appelgren J; Zhou W; Jirström K; Bergh J; Wärnberg F
    Eur J Cancer; 2014 Feb; 50(3):517-24. PubMed ID: 24275214
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ductal carcinoma in situ that involves sclerosing adenosis: high frequency of bilateral breast cancer occurrence.
    Yoshida A; Hayashi N; Akiyama F; Yamauchi H; Uruno T; Kikuchi M; Yagata H; Tsugawa K; Suzuki K; Nakamura S; Tsunoda H
    Clin Breast Cancer; 2012 Dec; 12(6):398-403. PubMed ID: 23083502
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased prevalence of breast cancer among patients with thyroid and parathyroid disease.
    Garner CN; Ganetzky R; Brainard J; Hammel JP; Berber E; Siperstein AE; Milas M
    Surgery; 2007 Dec; 142(6):806-13; discussion 813.e1-3. PubMed ID: 18063060
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Multiple primary malignancies associated with thyroid cancer].
    Shinozaki N; Sakamoto A; Kasai N; Uchida M; Sakurai K
    Gan No Rinsho; 1983 Oct; 29(12):1385-91. PubMed ID: 6645058
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The risk of second primary malignancy is increased in differentiated thyroid cancer patients with a cumulative (131)I dose over 37 GBq.
    Khang AR; Cho SW; Choi HS; Ahn HY; Yoo WS; Kim KW; Kang KW; Yi KH; Park DJ; Lee DS; Chung JK; Cho BY; Park YJ
    Clin Endocrinol (Oxf); 2015 Jul; 83(1):117-23. PubMed ID: 25115234
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preoperative breast magnetic resonance imaging and contralateral breast cancer occurrence among older women with ductal carcinoma in situ.
    Wang SY; Long JB; Killelea BK; Evans SB; Roberts KB; Silber A; Gross CP
    Breast Cancer Res Treat; 2016 Jul; 158(1):139-148. PubMed ID: 27287780
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk of second primary malignancies in women with papillary thyroid cancer.
    Canchola AJ; Horn-Ross PL; Purdie DM
    Am J Epidemiol; 2006 Mar; 163(6):521-7. PubMed ID: 16421240
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk of contralateral second primary breast cancer according to hormone receptor status in Germany.
    Rusner C; Wolf K; Bandemer-Greulich U; Engel J; Stegmaier C; Holleczek B; Schubert-Fritschle G; Tillack A; Stang A
    Breast Cancer Res; 2014 Oct; 16(5):452. PubMed ID: 25277819
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Different distribution of breast cancer subtypes in breast ductal carcinoma in situ (DCIS), DCIS with microinvasion, and DCIS with invasion component.
    Yu KD; Wu LM; Liu GY; Wu J; Di GH; Shen ZZ; Shao ZM
    Ann Surg Oncol; 2011 May; 18(5):1342-8. PubMed ID: 21042943
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Single-Center Retrospective Study of Patients with Double Primary Cancers: Breast Cancer and EGFR-Mutant Non-Small Cell Lung Cancer.
    Moran T; Quiroga V; Cirauqui B; Vila L; Gil-Moreno M; Carcereny E; Margeli M; Muñoz-Marmol A; Mate JL; Velarde JM; Molina MA; Rosell R
    Oncol Res Treat; 2019; 42(3):107-114. PubMed ID: 30799393
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Breast Cancer in Men: a Report from the Department of Radiation Oncology in Kermanshah Province, Iran.
    Amirifard N; Sadeghi E
    Asian Pac J Cancer Prev; 2016; 17(5):2593-6. PubMed ID: 27268636
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Italian cancer figures, report 2013: Multiple tumours.
    AIRTUM Working Group
    Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Body weight and risk of molecular breast cancer subtypes among postmenopausal Mediterranean women.
    Crispo A; Montella M; Buono G; Grimaldi M; D'Aiuto M; Capasso I; Esposito E; Amore A; Nocerino F; Augustin LS; Giudice A; Di Bonito M; Giuliano M; Forestieri V; De Laurentiis M; Rinaldo M; Ciliberto G; De Placido S; Arpino G
    Curr Res Transl Med; 2016; 64(1):15-20. PubMed ID: 27140595
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is there 'progression through grade' in ductal invasive breast cancer?
    Schymik B; Buerger H; Krämer A; Voss U; van der Groep P; Meinerz W; van Diest PJ; Korsching E
    Breast Cancer Res Treat; 2012 Oct; 135(3):693-703. PubMed ID: 22886478
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Second primary breast and thyroid cancers (Israel).
    Sadetzki S; Calderon-Margalit R; Peretz C; Novikov I; Barchana M; Papa MZ
    Cancer Causes Control; 2003 May; 14(4):367-75. PubMed ID: 12846369
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinicopathological and Immunohistochemical Characteristics in Male Breast Cancer: A Retrospective Case Series.
    Masci G; Caruso M; Caruso F; Salvini P; Carnaghi C; Giordano L; Miserocchi V; Losurdo A; Zuradelli M; Torrisi R; Di Tommaso L; Tinterri C; Testori A; Garcia-Etienne CA; Gatzemeier W; Santoro A
    Oncologist; 2015 Jun; 20(6):586-92. PubMed ID: 25948676
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mammographic breast density is associated with the development of contralateral breast cancer.
    Raghavendra A; Sinha AK; Le-Petross HT; Garg N; Hsu L; Patangan M; Bevers TB; Shen Y; Banu A; Tripathy D; Bedrosian I; Barcenas CH
    Cancer; 2017 Jun; 123(11):1935-1940. PubMed ID: 28135395
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Estrogen, progesterone, and Her-2/neu receptor expression discrepancy in primary tumors and in-breast relapse in patients with breast cancer.
    Mavrova R; Radosa J; Schmitt K; Bohle RM; Rody A; Solomayer EF; Juhasz-Böess I
    Breast J; 2014; 20(3):322-4. PubMed ID: 24720257
    [No Abstract]   [Full Text] [Related]  

  • 39. Incidence of second primary malignancy after breast cancer and related risk factors-Is breast-conserving surgery safe? A nested case-control study.
    Li Z; Wang K; Shi Y; Zhang X; Wen J
    Int J Cancer; 2020 Jan; 146(2):352-362. PubMed ID: 30861567
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is breast cancer from Sub Saharan Africa truly receptor poor? Prevalence of ER/PR/HER2 in breast cancer from Kenya.
    Sayed S; Moloo Z; Wasike R; Bird P; Oigara R; Govender D; Kibera J; Carrara H; Saleh M
    Breast; 2014 Oct; 23(5):591-6. PubMed ID: 25012047
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.